Acumen Pharmaceuticals, Inc.ABOSNASDAQ
Loading
Year-over-year net income growth rate
Latest
35.41%
↑ 122% vs avg
Percentile
P91
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-162.33%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 35.41% |
| Q2 2025 | -42.21% |
| Q1 2025 | 22.50% |
| Q4 2024 | -24.82% |
| Q3 2024 | -44.93% |
| Q2 2024 | -38.08% |
| Q1 2024 | 9.84% |
| Q4 2023 | -27.32% |
| Q3 2023 | -11.60% |
| Q2 2023 | -2.68% |
| Q1 2023 | 12.12% |
| Q4 2022 | -20.13% |
| Q3 2022 | -5.51% |
| Q2 2022 | -11.20% |
| Q1 2022 | -9.34% |
| Q4 2021 | -113.97% |
| Q3 2021 | 93.64% |
| Q2 2021 | -127.28% |
| Q1 2021 | -3475.76% |
| Q4 2020 | 69.68% |
| Q3 2020 | -22.36% |
| Q2 2020 | 0.49% |
| Q1 2020 | 0.00% |